Tally M Largent-Milnes Selected Research

Opioid Analgesics (Opioids)

1/2024	Problems in management of medication overuse headache in transgender and gender non-conforming populations.
11/2023	Morphine-induced osteolysis and hypersensitivity is mediated through toll-like receptor-4 in a murine model of metastatic breast cancer.
1/2023	Green Light Exposure Elicits Anti-inflammation, Endogenous Opioid Release and Dampens Synaptic Potentiation to Relieve Post-surgical Pain.
1/2023	The endocannabinoid system and breathing.
10/2022	Brain Penetrant, but not Peripherally Restricted, Synthetic Cannabinoid 1 Receptor Agonists Promote Morphine-Mediated Respiratory Depression.
12/2021	Green Light Antinociceptive and Reversal of Thermal and Mechanical Hypersensitivity Effects Rely on Endogenous Opioid System Stimulation.
10/2021	Cannabinoid-2 Agonism with AM2301 Mitigates Morphine-Induced Respiratory Depression.
1/2021	The Effects of Repeated Morphine Treatment on the Endogenous Cannabinoid System in the Ventral Tegmental Area.
1/2020	Activation of sphingosine-1-phosphate receptor subtype 1 in the central nervous system contributes to morphine-induced hyperalgesia and antinociceptive tolerance in rodents.
1/2020	Glial neuroimmune signaling in opioid reward.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tally M Largent-Milnes Research Topics

Disease

32	Pain (Aches) 03/2024 - 08/2008
13	Hyperalgesia 10/2023 - 08/2008
11	Neuralgia (Stump Neuralgia) 01/2023 - 08/2008
9	Chronic Pain 01/2023 - 03/2010
8	Migraine Disorders (Migraine) 01/2024 - 12/2017
7	Hypersensitivity (Allergy) 11/2023 - 08/2008
7	Neoplasms (Cancer) 01/2020 - 04/2010
5	Cancer Pain 10/2023 - 01/2013
4	Inflammation (Inflammations) 10/2023 - 01/2019
4	Respiratory Insufficiency (Respiratory Failure) 01/2023 - 01/2020
4	Acute Pain 01/2018 - 09/2015
3	Headache (Headaches) 01/2024 - 01/2020
3	Breast Neoplasms (Breast Cancer) 11/2023 - 01/2013
3	Peripheral Nervous System Diseases (PNS Diseases) 10/2023 - 01/2020
3	Opioid-Related Disorders (Opiate Addiction) 10/2021 - 01/2020
3	Bone Neoplasms (Bone Cancer) 01/2018 - 04/2010
2	Substance-Related Disorders (Drug Abuse) 01/2024 - 01/2023
2	Hypertension (High Blood Pressure) 01/2024 - 01/2019
2	Secondary Headache Disorders 01/2024 - 01/2020
2	Nervous System Diseases (Neurological Disorders) 12/2023 - 01/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2019
2	Neuroinflammatory Diseases 01/2023 - 01/2020
2	Postoperative Pain 01/2023 - 07/2015
2	Catalepsy 09/2018 - 04/2010
2	Hypothermia 09/2018 - 04/2010
1	Primary Headache Disorders 01/2024
1	Stroke (Strokes) 12/2023
1	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2023
1	Osteolysis 11/2023
1	Bone Diseases (Bone Disease) 10/2023
1	Opiate Overdose 01/2023
1	Apnea 01/2023
1	Seasonal Affective Disorder 01/2023
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023
1	Hyperemia 11/2022
1	Herpes Zoster 07/2022
1	Brain Concussion (Cerebral Concussion) 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Fibromyalgia (Fibrositis) 12/2021

Drug/Important Bio-Agent (IBA)

23	Opioid Analgesics (Opioids)IBA 01/2024 - 08/2008
13	Analgesics (Analgesic Drugs)IBA 01/2024 - 04/2010
13	Morphine (MS Contin)FDA LinkGeneric 11/2023 - 03/2012
6	CannabinoidsIBA 01/2023 - 04/2010
5	Sumatriptan (Imigran)FDA LinkGeneric 01/2024 - 12/2017
5	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2023 - 03/2012
5	LigandsIBA 01/2016 - 03/2010
4	EndocannabinoidsIBA 12/2023 - 01/2020
4	angiotensin I (1-7)IBA 10/2023 - 12/2016
3	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2024 - 01/2021
3	Hormones (Hormone)IBA 01/2024 - 01/2021
3	Peptides (Polypeptides)IBA 10/2023 - 06/2011
3	Estrogens (Estrogen)FDA Link 01/2023 - 12/2017
3	CytokinesIBA 01/2022 - 01/2013
3	SphingolipidsIBA 01/2020 - 09/2017
3	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2020 - 09/2017
2	Ibuprofen (Motrin)FDA LinkGeneric 01/2024 - 01/2023
2	CarrageenanIBA 10/2023 - 07/2015
2	EnzymesIBA 01/2023 - 01/2020
2	anandamide (arachidonylethanolamide)IBA 01/2023 - 01/2020
2	Ion Channels (Ion Channel)IBA 10/2022 - 01/2019
2	PrNMIIBA 10/2022 - 09/2018
2	morpholineIBA 10/2022 - 09/2018
2	Opioid Receptors (Opioid Receptor)IBA 12/2021 - 06/2011
2	Fingolimod Hydrochloride (FTY720)FDA Link 01/2020 - 09/2017
2	Calcium Channels (Calcium Channel)IBA 01/2020 - 07/2015
2	compound 20IBA 01/2020 - 09/2015
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2020 - 01/2020
2	Sphingosine-1-Phosphate ReceptorsIBA 01/2020 - 01/2019
2	Opiate AlkaloidsIBA 01/2013 - 04/2010
2	AM 1241IBA 03/2012 - 04/2010
1	Tryptamines (Triptans)IBA 01/2024
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2024
1	Toll-Like Receptor 4IBA 11/2023
1	ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA 11/2023
1	PlatinumIBA 10/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2023
1	Therapeutic UsesIBA 10/2023
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 01/2023
1	Testosterone (Sustanon)FDA Link 01/2023
1	AndrogensIBA 01/2023
1	Gonadal HormonesIBA 01/2023
1	HydrolasesIBA 01/2023
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 01/2023
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2023
1	Monoacylglycerol LipasesIBA 01/2023
1	Progesterone FDA LinkGeneric 01/2023
1	ProlactinIBA 01/2023
1	Protein Isoforms (Isoforms)IBA 12/2022
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 11/2022
1	ezogabine (retigabine)IBA 10/2022
1	volinanserinIBA 10/2022
1	ProteomeIBA 07/2022
1	OccludinIBA 07/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2021

Therapy/Procedure

21	Therapeutics 01/2024 - 08/2008
3	Pain Management 03/2024 - 01/2018
3	Analgesia 10/2021 - 01/2013
2	Drug Therapy (Chemotherapy) 10/2023 - 01/2020
1	Phototherapy (Light Therapy) 01/2023
1	Lasers (Laser) 11/2022